Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 61043

1205 Texas Avenue, Suite 700, Lubbock, 

Texas 79401, and at U.S. EPA Region 6, 

1445 Ross Avenue, Dallas, Texas 75202. 

During the public comment period, the 

Consent Decree, may also be examined 

on the following Department of Justice 

Web site, http://www.usdoj.gov/enrd/

open.html. A copy of the Consent 

Decree may also be obtained by mail 

from the Consent Decree Library, P.O. 

Box 7611, U.S. Department of Justice, 

Washington, DC 20044–7611 or by 

faxing or e-mailing a request to Tonia 

Fleetwood (tonia.fleetwood@usdoj.gov), 

fax no. (202) 514–0097, phone 

confirmation number (202) 514–1547. In 

requesting a copy from the Consent 

Decree Library, please enclose a check 

in the amount of $12.00 (25 cents per 

page reproduction cost) payable to the 

U.S. Treasury.

Thomas A. Mariani, Jr., 

Assistant Chief, Environmental Enforcement 

Section, Environment and Natural Resources 

Division.

[FR Doc. 04–23096 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–15–M

DEPARTMENT OF JUSTICE

Notice of Lodging of Stipulated Order 

To Amend Consent Judgment Under 

Environmental Laws and Partially 

Substitute Parties 

Notice is hereby given that on October 

8, 2004, a proposed Stipulated Order 

was lodged with the United States 

District Court for the Eastern District of 

Michigan in United States v. Velsicol 

Chemical Corp., No. 82–10303 (E.D. 

Mich.). The Stipulated Order among the 

United States on behalf of the 

Environmental Protection Agency, the 

State of Michigan, and Velsicol 

Chemical Corporation (‘‘Velsicol’’) 

would substitute the Custodial Trust 

created in the bankruptcy settlement 

agreement in In re Fruit of the Loom, 

Inc., No. 99–4497 (Bankr. D. Del.) for 

Velsicol and would resolve Velsicol’s 

obligations under the 1982 Consent 

Judgment as provided in the Stipulated 

Order and the bankruptcy settlement 

agreement. The 1982 Consent Judgment 

concerns the St. Louis Facility in St. 

Louis, Gratiot County, Michigan. 

The Department of Justice will receive 

comments relating to the Stipulated 

Order for a period of thirty (30) days 

from the date of this publication. 

Comments should be addressed to the 

Assistant Attorney General, 

Environment and Natural Resources 

Division, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611, and should refer to United 

States v. Velsicol Chemical Corporation,

DJ Ref. No. 90–7–1–105. 

The Stipulated Order may be 

examined at the Office of the United 

States Attorney for the Eastern District 

of Michigan, 211 West Fort Street, Suite 

2001, Detroit, Michigan, and at the 

Region 5 Office of the United States 

Environmental Protection Agency, 77 

West Jackson Boulevard, Chicago, 

Illinois. During the public comment 

period, the Stipulated Order may also be 

examined on the following Department 

of Justice Web site, http://

www.usdoj.gov/enrd/open.html. A copy 

of the Stipulated Order may also be 

obtained by mail from the Consent 

Decree Library, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611 or by faxing or e-mailing a 

request to Tonia Fleetwood 

(tonia.fleetwood@usdoj.gov), fax no. 

(202) 514–0097, phone confirmation 

number (202) 514–1547. In requesting a 

copy from the Consent Decree Library, 

please enclose a check in the amount of 

$27.75 (25 cents per page reproduction 

cost) payable to the U.S. Treasury for 

the entire Stipulated Order and 

attachments or the amount of $3.00 for 

the Stipulated Order without 

attachments.

Bruce S. Gelber, 

Section Chief, Environmental Enforcement 

Section, Environment and Natural Resources 

Division.

[FR Doc. 04–23095 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–15–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2)(b) authorizing the importation 

of such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on May 24, 

2004, Cambrex North Brunswick, Inc., 

Technology Center of New Jersey, 661 

Highway One, North Brunswick, New 

Jersey 08902, made application by 

renewal to the Drug Enforcement 

Administration (DEA) for registration as 

an importer of Phenylacetone (8501), a 

basic class of controlled substance listed 

in Schedule II. 

The company plans to import the 

controlled substance to manufacture 

amphetamine. 

Any manufacturer who is presently, 

or is applying to be, registered with DEA 

to manufacture such basic class of 

controlled substance may file comments 

or objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections or 

requests for hearing may be addressed, 

in quintuplicate, to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, United States 

Department of Justice, Washington, DC 

20537, Attention: DEA Federal Register 

Representative (CCD) and must be filed 

no later than November 15, 2004. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e) and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–43746), all applicants for 

registration to import a basic class of 

any controlled substances in Schedule I 

or II are and will continue to be required 

to demonstrate to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c),(d),(e) and (f) are 

satisfied.

Dated: September 28, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–23056 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to 21 CFR 1301.33(a), this is 

notice that on July 6, 2004, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78664, made 

application by renewal to the Drug 

Enforcement Administration (DEA) for 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed:

61044 Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 

Drug Schedule 

Cathinone (1235) ........................ I 

Methcathinone (1237) ................. I 

N-Ethylamphetamine (1475) ....... I 

N,N-Dimethylamphetamine 

(1480).

I 

Aminorex (1585) ......................... I 

4-Methylaminorex (cis isomer) 

(1590).

I 

Gamma hydroxybutyric acid 

(2010).

I 

Methaqualone (2565) ................. I 

Alpha-Ethyltryptamine (7249) ..... I 

Lysergic acid diethylamide 

(7315).

I 

Tetrahydrocannabinols (7370) .... I 

Mescaline (7381) ........................ I 

3,4,5-Trimethoxyamphetamine 

(7390).

I 

4-Bromo-2,5-

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5-

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5-

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

2,5-Dimethoxy-4-

ethylamphetamine (7399).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

5-Methoxy-3,4-

methylenedioxyamphetamine 

(7401).

I 

N-Hydroxy-3,4-

methylendioxyamphetamine 

(7402).

I 

3,4-Methylendioxy-Nethylamphetamine (7404).I 

3,4-Methylenedioxymethamphetamine (7405).I 

4-Methoxyamphetamine (7411) .. I 

Bufotenine (7433) ....................... I 

Diethyltryptamine (7434) ............ I 

Dimethyltryptamine (7435) ......... I 

Psilocybin (7437) ........................ I 

Psilocyn (7438) ........................... I 

Acetyldihydrocodeine (9051) ...... I 

Benzylmorphine (9052) .............. I 

Codeine-N-oxide (9053) ............. I 

Dihydromorphine (9145) ............. I 

Heroin (9200) .............................. I 

Hydromorphinol (9301) ............... I 

Methyldihydromorphine (9304) ... I 

Morphine-N-oxide (9307) ............ I 

Normorphine (9313) ................... I 

Pholcodine (9314) ...................... I 

Acetylmethadol (9601) ................ I 

Allylprodine (9602) ...................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alphameprodine (9604) .............. I 

Alphamethadol (9605) ................ I 

Betacetylmethadol (9607) ........... I 

Betameprodine (9608) ................ I 

Betamethadol (9609) .................. I 

Betaprodine (9611) ..................... I 

Hydroxypethidine (9627) ............ I 

Noracymethadol (9633) .............. I 

Norlevorphanol (9634) ................ I 

Normethadone (9635) ................ I 

Trimeperidine (9646) .................. I 

Phenomorphan (9647) ................ I 

Para-Fluorofentanyl (9812) ......... I 

Drug Schedule 

3-Methylfentanyl (9813) .............. I 

Alpha-Methylfentanyl (9814) ....... I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Beta-hydroxyfentanyl (9830) ...... I 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Alpha-Methylthiofentanyl (9832) I 

3-Methylthiofentanyl (9833) ........ I 

Thiofentanyl (9835) ..................... I 

Amphetamine (1100) .................. II 

Methamphetamine (1105) .......... II 

Phenmetrazine (1631) ................ II 

Methylphenidate (1724) .............. II 

Ambobarbital (2125) ................... II 

Pentobarbital (2270) ................... II 

Secobarbital (2315) .................... II 

Glutethimide (2550) .................... II 

Nabilone (7379) .......................... II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................. II 

1-Piperidinocyclohexanecarbonitrile (8603).II 

Alphaprodine (9010) ................... II 

Cocaine (9041) ........................... II 

Codeine (9050) ........................... II 

Dihydrocodeine (9120) ............... II 

Oxycodone (9143) ...................... II 

Hydromorphone (9150) .............. II 

Diphenoxylate (9170) ................. II 

Benzoylecgonine (9180) ............. II 

Ethylmorphine (9190) ................. II 

Hydrocodone (9193) ................... II 

Levomethorphan (9210) ............. II 

Levorphanol (9220) .................... II 

Isomethadone (9226) ................. II 

Meperidine (9230) ...................... II 

Methadone (9250) ...................... II 

Methadone-intermediate (9254) II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ......................... II 

Thebaine (9333) ......................... II 

Levo-alphacetylmethadol (9648) II 

Oxymorphone (9652) .................. II 

Noroxymorphone (9668) ............. II 

Racemethorphan (9732) ............. II 

Alfentanil (9737) ......................... II 

Sufentanil (9740) ........................ II 

Fentanyl (9801) .......................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

for distribution to their customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative (CCD) 

and must be filed no later than 

December 13, 2004.

Dated: September 28, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–23053 Filed 10–13–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2)(B) authorizing the importation 

of such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on June 

29, 2004, Cerilliant Corporation, 811 

Paloma Drive, Suite A, Round Rock, 

Texas 78664, made application by 

renewal to the Drug Enforcement 

Administration (DEA) for registration as 

an importer of the basic classes of 

controlled substances listed below:

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) ................... I 

N-Ethylamphetamine (1475) ......... I 

Gamma hydroxybutyric acid 

(2010) ........................................ I 

Ibogaine (7260) ............................ I 

Tetrahydrocannabinols (7370) ...... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5-

dimethoxyamphetamine (7391) I 

4-Bromo-2,5-

dimethoxyphenethylamine 

(7392) ........................................ I 

4-Methyl-2,5-

dimethoxyamphetamine (7395) I 

2,5-Dimethoxyamphetamine 

(7396) ........................................ I 

3,4-Methylenedioxyamphetamine (7400) ................. I 

3,4-Methylenedioxymethamphetamine (7404) ................. I 

3,4-Methylenedioxymethamphetamine (7405) ................. I 

4-Methoxyamphetamine (7411) .... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

Etorphine (9056) ........................... I 

Heroin (9200) ................................ I 

Pholcodine (9314) ........................ I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Cocaine (9041) ............................. II